Republish
JUUL and tobacco
We love that you want to share our stories with your readers. Hundreds of publications republish our work on a regular basis.
All of the articles at CalMatters are available to republish for free, under the following conditions:
-
- Give prominent credit to our journalists: Credit our authors at the top of the article and any other byline areas of your publication. In the byline, we prefer “By Author Name, CalMatters.” If you’re republishing guest commentary (example) from CalMatters, in the byline, use “By Author Name, Special for CalMatters.”
-
- Credit CalMatters at the top of the story: At the top of the story’s text, include this copy: “This story was originally published by CalMatters. Sign up for their newsletters.” If you are republishing commentary, include this copy instead: “This commentary was originally published by CalMatters. Sign up for their newsletters.” If you’re republishing in print, omit the second sentence on newsletter signups.
-
- Do not edit the article, including the headline, except to reflect relative changes in time, location and editorial style. For example, “yesterday” can be changed to “last week,” and “Alameda County” to “Alameda County, California” or “here.”
-
- If you add reporting that would help localize the article, include this copy in your story: “Additional reporting by [Your Publication]” and let us know at republish@calmatters.org.
-
- If you wish to translate the article, please contact us for approval at republish@calmatters.org.
-
- Photos and illustrations by CalMatters staff or shown as “for CalMatters” may only be republished alongside the stories in which they originally appeared. For any other uses, please contact us for approval at visuals@calmatters.org.
-
- Photos and illustrations from wire services like the Associated Press, Reuters, iStock are not free to republish.
-
- Do not sell our stories, and do not sell ads specifically against our stories. Feel free, however, to publish it on a page surrounded by ads you’ve already sold.
-
- Sharing a CalMatters story on social media? Please mention @CalMatters. We’re on X, Facebook, Instagram, TikTok and BlueSky.
If you’d like to regularly republish our stories, we have some other options available. Contact us at republish@calmatters.org if you’re interested.
Have other questions or special requests? Or do you have a great story to share about the impact of one of our stories on your audience? We’d love to hear from you. Contact us at republish@calmatters.org.
JUUL and tobacco
Share this:
Steve Heilig, former co-chair, San Francisco Tobacco-Free Coalition
Ashley Gould of JUUL Labs is in denial in defending JUUL’s partnership with the world’s biggest marketer of toxic addicting tobacco.
Decades of tobacco industry deceit have taught us to follow the money rather than their words, and JUUL is now using messages and tactics remarkably similar to longtime tobacco propaganda. Can anybody truly believe Altria and JUUL want to reduce use of their products?
It is far wiser to trust research and experience, which increasingly show that youth are a prime market for nicotine addiction via any route, that converting to vaping leaves users still hooked on nicotine, that e-cigs are also harmful to one’s heart and lungs and expose bystanders to secondhand toxins, and more harmful impacts.
Small wonder that the tobacco and vaping industry fight so forcefully and spend so much against public health policies such as bans on flavored and menthol products. We need to watch what they do, not what they say.